89Zr-DFO-daratumumab Has Potential Imaging Benefits in Non-FDG–Avid Multiple MyelomaByGina MauroJune 30th 202589Zr-DFO-daratumumab shows activity in identifying and localizing multiple myeloma, even in FDG-non-avid cases, per new phase 2 data.